Relationship between sleep and acid gastro-oesophageal reflux in neonates

Mohamed Ammari1, Djamal Djeddi, André Léké

  • 1PériTox Laboratory (EA4285-UMI 01 INERIS), Jules Verne University of Picardy, 3 rue des Louvels, Amiens, France.

Insights

Gastro-oesophageal reflux in neonates occurs more during wakefulness but has a greater impact during sleep. Active sleep promotes acid migration, while quiet sleep risks prolonged acid contact.

Area of Science:

  • Neonatal physiology
  • Gastroenterology
  • Sleep medicine

Background:

  • Gastro-oesophageal reflux (GOR) is common in neonates.
  • Understanding the interplay between GOR and sleep is crucial for infant health.
  • Previous research has not fully elucidated how sleep states influence GOR characteristics.

Purpose of the Study:

  • To investigate the impact of acid reflux on neonatal sleep.
  • To determine how wakefulness (W) and sleep stages affect GOR characteristics.
  • To analyze retrograde bolus migration of oesophageal acid contents during different vigilance states.

Main Methods:

  • Nocturnal polysomnography with pH and multichannel intraluminal impedance monitoring.
  • Study included 25 infants hospitalized for suspected GOR.
  • Infants were divided into reflux and control groups.

Main Results:

  • No significant differences in sleep duration, structure, or state change frequency between groups.
  • GOR occurred more frequently during W (59%) and active sleep (AS; 35%) than quiet sleep (QS; 6%).
  • Mean GOR duration was longer in QS; retrograde bolus migration was higher in AS (62%) than W (42%) and QS (4.5%).

Conclusions:

  • Neonatal GOR occurs more frequently during wakefulness.
  • Sleep state transitions significantly influence GOR patterns and impact.
  • Active sleep facilitates acid migration, while quiet sleep increases the risk of prolonged acid mucosal contact.

Related Concept Videos

Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...